+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Veterinary Biologics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4749577
  • Report
  • Region: Global
  • Acute Market Reports
1 of 3

FEATURED COMPANIES

  • Ceva Sante Animale
  • Evonik Industries AG
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL Bioscience
  • Intetvet, Inc.
  • MORE
The global veterinary biologics market was valued at US$ 17,704.7 Mn in 2017 and is expected to reach US$ 29,706.9 Mn by 2026, expanding at a CAGR of 6.0% from 2018 to 2026.

Market Insights:

As per the latest research findings provided by United Nations Department of Economic and Social Affairs, the current global population is 7.7 billion with insufficient food supply to provide nourishment to the entire population. Government agencies worldwide are focusing on sustainable development ensuring total food security and promoting animal health. Rising consumption of proteins and increasing public animal health awareness drive the veterinary biologics market. Dearth of skilled workforce and higher cost associated with storage of veterinary vaccines and diagnostic kits hamper the veterinary biologics market growth.

Vaccines are reigning the product segment for veterinary biologics market. Impending global threat of veterinary diseases such as bird flu, swine flu, rabies, contagious bovine pleuropneumonia etc., drive the veterinary vaccines market growth. Technological innovation in molecular biology has resulted in blockbuster sale of veterinary diagnostic kits resulting in early disease diagnosis and treatment. Nutritional and hormonal supplement will be the fastest growing market in the product segment on account of increasing demand for animal derived protein consumption and rampant growth in animal husbandry segment worldwide.

In the present scenario production animal are leading the animal type segment for veterinary biologics market. Proactive government policies ensuring total food security and improving livestock healthcare drive the production animal market growth. Rampant growth in dairy industry further consolidate the production animal market growth. Companion animals will register significant growth in the near future owing to significant growth in pet adoption and compulsory immunization of pet animals.

North America is the largest regional segment in the veterinary biologics market accounting for a market share of 40%. Existence of well-developed agrobased and animal husbandry department and domicile of key players such as IDEXX Laboratories, Inc., Virbac, Inc., and Zoetis drive the veterinary biologics market growth in North America region. Europe represents 31% market share owing to rampant growth in meat and dairy industry and stringent government policies for effective vaccination of companion animals. Asia Pacific holds 17% market share and will be the fastest growing regional segment during the forecast period on account of rising prevalence of zoonotic disease and proactive government policies to financially support animal healthcare department.
Biopharmaceutical companies actively participating in veterinary biologics market are Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Evonik Industries AG, Heska Corporation, Intervet, Inc., INDICAL Bioscience, IDEXX Laboratories, Inc., Virbac, Inc., VCA, Inc. and Zoetis.

Key Market Movements:
  • Rising prevalence of veterinary diseases and proactive government policies securing total food security and improving livestock healthcare
  • Significant growth in pet adoption and stringent government norms ensuring mandatory vaccination of pet animals
  • Technological revolution in molecular biology producing effective diagnostic kits, vaccines and animal feed related to veterinary health science
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Ceva Sante Animale
  • Evonik Industries AG
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL Bioscience
  • Intetvet, Inc.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Veterinary Biologics Market Portraiture
2.2. Global Veterinary Biologics Market, by Product, 2017 (US$ Mn)
2.3. Global Veterinary Biologics Market, by Type, 2017 (US$ Mn)
2.4. Global Veterinary Biologics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Veterinary Biologics Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Veterinary Biologics Market, by Key Players, 2017

Chapter 4. Global Veterinary Biologics Market, by Product
4.1. Overview
4.2. Vaccines
4.3. Diagnostic Kits
4.4. Nutritional and Hormonal Supplement
4.5. Allergenic Extract
4.6. Others

Chapter 5. Global Veterinary Biologics Market, by Type
5.1. Overview
5.2. Production Animal
5.3. Companion Animal

Chapter 6. Global Veterinary Biologics Market, by Geography
6.1. Overview
6.2. North America Veterinary Biologics Market Analysis, 2016 – 2026
6.2.1. North America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.2.3. North America Veterinary Biologics Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Veterinary Biologics Market Analysis, 2016 – 2026
6.3.1. Europe Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.3.3. Europe Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Veterinary Biologics Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Veterinary Biologics Market Analysis, 2016 – 2026
6.5.1. Latin America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa Veterinary Biologics Market Analysis, 2016 – 2026
6.6.1. MEA Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
6.6.3. MEA Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim Animal Health GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Ceva Sante Animale
7.3. Evonik Industries AG
7.4. Heska Corporation
7.5. Intetvet, Inc.
7.6. INDICAL Bioscience
7.7. IDEXX Laboratories, Inc.
7.8. Virbac, Inc.
7.9. VCA, Inc.
7.10. Zoetis

List of Figures
FIG. 1 Veterinary Biologics Market: Research Methodology
FIG. 2 Veterinary Biologics: Market Segmentation
FIG. 3 Global Veterinary Biologics Market, by Product, 2017 (US$ Mn)
FIG. 4 Global Veterinary Biologics Market, by Type, 2017 (US$ Mn)
FIG. 5 Global Veterinary Biologics Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global Veterinary Biologics Market, by Key Players, 2017
FIG. 8 Global Vaccines Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 9 Global Diagnostic Kits Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nutritional and Hormonal Supplements Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 11 Global Allergenic Extracts Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Products Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 13 Global Production Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 14 Global Companion Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 20 China Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC Veterinary Biologics Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA Veterinary Biologics Market, 2016 – 2026 (US$ Mn)

List of Tables
TABLE 1 Global Veterinary Biologics Market Portraiture
TABLE 2 Global Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Veterinary Biologics Market , by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Veterinary Biologics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America Veterinary Biologics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Veterinary Biologics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Veterinary Biologics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa Veterinary Biologics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Boehringer Ingelheim Animal Health GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Ceva Sante Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Evonik Industries AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Heska Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Intervet, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 INDICAL Bioscience.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 IDEXX Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Virbac, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 VCA, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boehringer Ingelheim Animal Health GmbH
  • Ceva Sante Animale
  • Evonik Industries AG
  • Heska Corporation
  • Intetvet, Inc.
  • INDICAL Bioscience
  • IDEXX Laboratories, Inc.
  • Virbac, Inc.
  • VCA, Inc.
  • Zoetis
Note: Product cover images may vary from those shown
Adroll
adroll